FGF2 and chronic myelogenous leukemia, BCR-ABL1 positive: We found that FGF2 expression was increased in CML and AML stroma during the development of resistance to kinase inhibitors, indicating that FGF2 expression is a regulated autocrine growth factor for stroma (Traer et al., 2016).